News & Updates

Recurrent node-positive breast cancer reveals distant metastasis in patients
Recurrent node-positive breast cancer reveals distant metastasis in patients
12 Feb 2022

Distant metastasis is present in all patients with node-positive breast cancer (NPBC) at the time of recurrence, reveals a study. Compared with diffusely metastatic (DM) patients, those with oligometastasis (OM) have shorter time to recurrence but longer overall survival (OS).

Recurrent node-positive breast cancer reveals distant metastasis in patients
12 Feb 2022
Which factor impels offering of postoperative chemotherapy in nonmuscle invasive bladder cancer?
Which factor impels offering of postoperative chemotherapy in nonmuscle invasive bladder cancer?
11 Feb 2022
Immune-related adverse events signal better survival in non-Hodgkin lymphoma patients on ICI
Immune-related adverse events signal better survival in non-Hodgkin lymphoma patients on ICI
11 Feb 2022

The development of immune-related adverse events (irAEs) in non-Hodgkin lymphoma (NHL) patients treated with immune checkpoint inhibitors (ICI) may indicate better long-term survival, a recent study has found.

Immune-related adverse events signal better survival in non-Hodgkin lymphoma patients on ICI
11 Feb 2022
Bivalent HPV vaccine substantially reduces cervical cancer, CIN3 rates
Bivalent HPV vaccine substantially reduces cervical cancer, CIN3 rates
10 Feb 2022 byRoshini Claire Anthony

The risk of cervical cancer and grade 3 cervical intraepithelial neoplasia (CIN3) was substantially reduced among girls who were offered the bivalent human papillomavirus (HPV) vaccine, particularly those who were offered it at age 12–13 years, according to an observational study from England.

Bivalent HPV vaccine substantially reduces cervical cancer, CIN3 rates
10 Feb 2022
Obesity, diabetes, family history up prostate cancer risk in IBD patients
Obesity, diabetes, family history up prostate cancer risk in IBD patients
10 Feb 2022 byStephen Padilla

A longitudinal national database study of patients with inflammatory bowel disease (IBD) has identified several risk factors for the development of prostate cancer (PC), including age, obesity, diabetes, married status, family history of PC, and African American race.

Obesity, diabetes, family history up prostate cancer risk in IBD patients
10 Feb 2022
Aspirin boosts survival in multiple myeloma
Aspirin boosts survival in multiple myeloma
09 Feb 2022

Multiple myeloma patients who use aspirin regularly show a survival advantage over their counterparts who do not use said agent, a study has found.

Aspirin boosts survival in multiple myeloma
09 Feb 2022
Adherence to lenalidomide deficient in multiple myeloma patients
Adherence to lenalidomide deficient in multiple myeloma patients
07 Feb 2022